Dr Marisa Flook is a Volunteer Writer at BioNews, having originally joined under the auspices of its writing scheme. She is currently a postdoctoral researcher in Dr Mike Bowl's group at University College London Ear Institute, where she studies hearing loss genetics. Marisa completed her PhD in biomedicine at the University of Granada, Spain, focusing her research on the immunological background of Meniere's disease. She studied anatomical pathology, cytology and thanatology at the School of Health Polytechnic of Porto, Portugal. Additionally, she holds an MSc in molecular biology and genetics from the University of Lisbon, Portugal.
CRISPR-based genome editing has been used to overcome chemotherapy resistance in lung tumours by disabling a tumour-specific mutation...
Extremely advanced ageing and poor health are not intrinsically linked, according to a study of the longest-lived supercentenarian...
A gene variant has been shown to have different effects on patients based on their genetic sex...
A new type of CAR-T immunotherapy that targets aggressive T-cell blood cancer shows high remission rates and manageable side effects, according to the results of an international clinical trial...
Methylation in the placentas of male and female fetuses has marked differences, according to a study by researchers at the National Institutes of Health, Bethesda, Maryland...
Ten out of 11 children with profound deafness enrolled in a gene therapy trial showed notable improvements in their hearing after a year...
Nearly 300 genomic regions associated with increased risk for bipolar disorder have been uncovered...
The transposon LINE1 is an essential regulator in early human development, researchers found...
Over 3000 genetic variants could disrupt normal function of the RAD51C breast and ovarian cancer gene...
A new gene therapy for haemophilia B is to be made available for NHS patients after approval from the UK's National Institute for Health and Care Excellence.
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
